摘要
目的:观察表没食子儿茶素没食子酸酯(EGCG)对APP/PS1转基因小鼠海马胰岛素受体底物-1(IRS-1)磷酸化的作用。方法:12月龄雌性APP/PS1小鼠随机分为模型组(Tg)、EGCG低剂量组(Tg/EGCG-L)、高剂量组(Tg/EGCG-H),同月龄雌性C57BL/6J小鼠作为对照组(NT)。采用Western blot和免疫组织化学方法检测各组小鼠海马IRS-1pSer636的表达。结果:与对照组比较,模型组小鼠海马IRS-1pSer636表达明显升高(P<0.05),EGCG各治疗组IRS-1pSer636表达较模型组降低(P<0.05)。结论:EGCG可以减轻APP/PS1小鼠海马胰岛素抵抗,其机制可能部分与减轻IRS-1在丝氨酸636位点的磷酸化水平有关。
OBJECTIVE To observe the effects of epigallocatechin-3 gallate (EGCG) on the expression of insulin receptor substrate-l(IRS-1) phosphorylation in the hippocampus of APP/PS1 transgenetie mice. METHODS 12 months old female APP/PS1 mice were randomly divided into 3 groups: model group(Tg), EC, CG low dose group (Tg /EGCC-L), high dose group(Tg/EGCG-H). C57BL/6J mice were utilized as control. The hippocampal IRS-lpSer636 level of each group was detected by Western blot and Immunohistochemical staining. RESULTS Compared with NT mice, the hippocampal IRS-lpSer636 level of Tg mice was increased significantly (P〈0. 05), Tg/EGCG-L and Tg/EGCG-H mice showed an obvious decrease of IRS-lpSer636 level in the hippocampus compared with Tg mice(P〈0. 05). CONCLUSION EGCG treatment is able to alleviate insulin resistance in the hippocampus of APP/PS1 mice, which may be partly attributed to the reduction of IRS-1pSer636 level in this mice model.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2014年第13期1072-1075,共4页
Chinese Journal of Hospital Pharmacy
基金
辽宁省科学技术计划项目(编号:2012225019)
辽宁省自然科学基金项目(编号:2013022028)